Balance Sheet for Alnylam Pharmaceuticals Inc. (ALNY)

$ 84.78   2.90 (+3.54%) Volume: 865.39k 4:00 PM EDT 18-Oct-2019
After Hours:  $ 84.78 0.00 (0.00%) Volume: 50.51k 4:46 PM EDT 18-Oct-2019
Statement: View:
Assets [+] in Millions of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Cash and Equivalents 420 645 194 181 75
Restrictable Cash - - - - -
Marketable Securities 664 1,045 433 900 622
Accounts Receivable 19 34 23 8 40
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables 19 34 23 8 40
Inventories, Raw Materials 9 - - - -
Inventories, Work in Progress 15 - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 0 - - - -
Inventories, Other 24 - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories 24 - - - -
Prepaid Expenses 74 40 22 17 10
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 1,201 1,765 672 1,105 746
Land and Improvements 9 9 9 - -
Buildings and Improvement 66 51 45 36 31
Machinery, Furniture and Equipment 64 56 53 42 35
Construction in Progress 261 134 68 1 2
Fixed Assets, Other - - - - -
Fixed Assets, Total 400 249 176 79 68
Gross Fixed Assets 400 249 176 79 68
Accumulated Depreciation (79) (67) (61) (51) (46)
Net Fixed Assets 321 182 115 28 22
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - 32
Other Non-Current Assets 9 4 2 1 -
Total Non-Current Assets 374 230 591 281 333
Total Assets 1,575 1,995 1,263 1,387 1,080
Liabilities [+] in Millions of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Accounts Payable 60 28 54 15 3
Short Term Debt - - - - -
Notes Payable - - - - -
Accrued Expenses 75 38 28 18 16
Accrued Liabilities 75 38 28 18 16
Deferred Revenues 3 42 34 15 24
Current Deferred Income Taxes - - - - -
Other Current Liabilities 41 36 15 14 20
Total Current Liabilities 179 144 132 62 95
Long Term Debt 30 30 150 - -
Deferred Income Tax 58 50 58 58 48
Other Non-Current Liabilities 63 54 61 60 48
Minority Interest - - - - -
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 93 84 211 60 48
Total Liabilities 273 228 343 122 143
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 1,302 1,766 920 1,265 936
Common Par 1 1 1 1 1
Additional Paid in Capital 4,175 3,948 2,610 2,506 1,843
Cumulative Translation Adjustments - - - - -
Retained Earnings (2,841) (2,148) (1,657) (1,247) (957)
Treasury Stock - - - - -
Other Equity Adjustments (33) (34) (33) 4 49
Total Capitalization 1,332 1,796 1,070 1,265 936
Total Equity 1,302 1,766 920 1,265 936
Total Liabilities & Shareholder's Equity 1,575 1,995 1,263 1,387 1,080
Cash Flow (761) (491) (410) (290) (360)
Working Capital 1,021 1,620 540 1,043 651
Free Cash Flow (690) (487) (372) (202) (175)
Invested Capital 1,332 1,796 1,070 1,265 936
Shares Outstanding - Common Class Only 101 100 86 85 77
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 101 100 86 85 77
Total Common Shares Outstanding 101 100 86 85 77
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 101 91 86 84 74
Diluted Weighted Shares Outstanding 101 91 86 84 74